Pretreatment Neutrophil: Lymphocyte Ratio as a Prognostic Factor in Cervical Carcinoma

This study was designed to investigate the prognostic value of the neutrophil:lymphocyte ratio (NLR) in cervical cancer. Patients with clinically staged cervical carcinoma (IB to IVA) at Samsung Medical Center, Seoul, Korea, from 1996 to 2007 were retrospectively enrolled. We enrolled 1061 patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2012-04, Vol.32 (4), p.1555-1561
Hauptverfasser:	LEE, Yoo-Young, CHEL HUN CHOI, KIM, Ha-Jeong, KIM, Tae-Joong, LEE, Jeong-Won, LEE, Je-Ho, BAE, Duk-Soo, KIM, Byoung-Gie
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Aged Aged, 80 and over Biological and medical sciences biomarkers Cervical cancer Cervical carcinoma Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Leukocytes (neutrophilic) Lymphocyte Count Lymphocytes Medical sciences Middle Aged Neutrophils Prognosis Survival Tumors Uterine Cervical Neoplasms - blood Uterine Cervical Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study was designed to investigate the prognostic value of the neutrophil:lymphocyte ratio (NLR) in cervical cancer. Patients with clinically staged cervical carcinoma (IB to IVA) at Samsung Medical Center, Seoul, Korea, from 1996 to 2007 were retrospectively enrolled. We enrolled 1061 patients with cervical cancer. The median NLR was 1.9, with a range of 0.3-27.0. When the cohort was divided according to the median NLR, poorer survival outcomes were observed in the group with higher NLR (≥1.9) than in the lower NLR group (
ISSN:	0250-7005 1791-7530